Cannara Biotech Inc. (TSXV:LOVE)

Market Cap	160.37M
Revenue (ttm)	107.20M
Net Income (ttm)	13.08M
Shares Out	94.90M
EPS (ttm)	0.14
PE Ratio	12.07
Forward PE	9.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,643
Average Volume	60,485
Open	1.660
Previous Close	1.670
Day's Range	1.660 - 1.710
52-Week Range	0.650 - 1.990
Beta	0.32
RSI	50.19
Earnings Date	Jan 26, 2026

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 452
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In 2025, Cannara Biotech's revenue was 107.20 million, an increase of 31.14% compared to the previous year's 81.75 million. Earnings were 13.08 million, an increase of 103.09%.